Viewing nowRostin Tablet 10mg (Rosuvastatin Calcium)
Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Aju Pharmaceutical Co., Ltd.

MFDS item code 201000967 · Approved 2010.01.28 · Insurance code 654003750
Improvement of dyslipidemia, inhibition of atherosclerosis progression, and prevention of cardiovascular disease
This medication is used as an adjunct therapy for patients with primary hypercholesterolemia and mixed dyslipidemia when dietary changes and exercise are insufficient. It is also beneficial for patients with homozygous familial hypercholesterolemia in conjunction with diet or other lipid-lowering therapies. It effectively controls total cholesterol and LDL cholesterol levels, thereby slowing the progression of atherosclerosis. It is also used as an adjunct to diet in pediatric patients with heterozygous familial hypercholesterolemia. It assists in the treatment of primary dysbetalipoproteinemia and helps reduce the risk of cardiovascular disease. In particular, it improves health by lowering the risk of stroke, myocardial infarction, and arterial revascularization procedures.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. The dose may be adjusted to a maintenance dose if a greater reduction in LDL cholesterol is needed. The maintenance dose is 10 milligrams once daily, which controls the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response. The dose may be increased to a maximum of 20 milligrams per day. 3. Older adults: No dose adjustment is required. 4. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering 20mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or lower, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended starting dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended starting dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of this medicine is contraindicated in some of these patients.
Ages 10 to 17 years: The usual dose range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on administering doses greater than 20 milligrams in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Under 10 years: Safety and efficacy have not been established.
This medication should not be administered to certain patients. For example, individuals allergic to any component of this medication, those with active liver disease, muscle disorders, or severe renal impairment should avoid taking it. Women who are pregnant, nursing, or who may become pregnant should not take this medication unless appropriate contraception is used, as there may be risks to the fetus. Those prone to myopathy or rhabdomyolysis should avoid high doses, including individuals with renal impairment, hypothyroidism, or family history. Periodic liver function tests are required before and during treatment with this medication, especially for individuals with a history of liver disease or excessive alcohol consumption. If symptoms such as muscle pain, weakness, or cramps occur, the patient should inform a physician immediately and seek testing. If severe muscle damage is suspected, the medication should be discontinued. This medication may interact with other drugs, so patients should inform healthcare providers of any other medications they are taking. Special caution is required when used with certain antivirals, immunosuppressants, or fibrate class drugs. The use of this medication during pregnancy or breastfeeding is not recommended, and women planning pregnancy should consult with a healthcare provider before use. In case of overdose, as there is no specific antidote, immediate medical attention should be sought for appropriate treatment, and monitoring of liver function and muscle enzyme levels is necessary. Care should be taken while driving or operating machinery as dizziness may occur. Finally, it is important to consult with healthcare providers if there are changes in physical condition or abnormal symptoms while taking this medication.
Allergic reactions, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, hives, muscle pain, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ocular muscle weakness, thrombocytopenia, jaundice, hepatitis, increase in transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, drug-induced lichenoid eruption, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, liver failure, cognitive impairment, increased ALT, chest pain, increased CK, increased AST, joint pain, fatigue, numbness, paresthesia, chest discomfort, loss of appetite, abdominal distension, syncope, pain all over the body, muscle cramps, gout, erectile dysfunction, acute kidney failure, oliguria, increased blood creatinine
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to keep out air and moisture and should be kept at room temperature between 1 and 30 degrees Celsius.
Pink round film-coated tablet
30 tablets / bottle, 300 tablets / bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Aju Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.